Kepal Patel at [NYU Langone Medical Center]

Kepal N. Patel, MD

  • Specialty: Endocrine Surgery
  • Language: English
  • Phone: 212-263-7710

About Me

Conditions and Treatments

thyroid surgery, thyroid cancer, thyroid nodule, hyperthyroidism, thyroid diseases, hyperparathyroidism, parathyroid disease, neck surgery, head and neck cancer, head and neck neoplasms, salivary gland tumor, parotid diseases, neck mass, mouth cancer, submandibular gland tumor, surgery, head surgery, neck exploration, adenoid cystic carcinoma, laryngeal cancer, mucoepidermoid carcinoma, squamous cell cancer, orbit tumor, adenocarcinoma, melanoma, skin cancer, eyelid tumor, basal cell cancer
Show More Conditions
Learn more about conditions we treat at NYU Langone:
Basal & Squamous Cell Skin Cancers, Melanoma

Credentials

Positions

  • Associate Professor, Department of Surgery
  • Associate Professor, Department of Biochemistry and Molecular Pharmacology
  • Associate Professor, Department of Otolaryngology
  • Dir Division of Endocrine Surgery

Board Certifications

    2003
  • AB Surgery - Surgery

Education and Training

  • 2004
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Head & Neck
  • 2002
  • Residency, Robert Wood Johnson Univ. Hosp., Surgery (General)
  • 1996
  • MD from Uni Of Med And Dentistry Of Nj

Departments

Locations and Appointments

56 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • American Imaging Network
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Touchstone Medicare
  • Tricare
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

NYU Endocrine Surgery Associates
530 1st Avenue, Suite 6H
New York, NY 10016

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Our laboratory has been interested in studying the molecular pathogenesis of thyroid carcinoma, specifically trying to identify molecular factors which can help predict thyroid tumor progression and potentially serve as therapeutic targets.

The optimal management of thyroid cancer is dependent on the assessment of the malignant potential of the individual tumor at presentation. Understanding the genetic mechanisms controlling thyroid tumor progression can provide valuable prognostic markers and potential therapeutic targets. Our research focuses on the changes in intracellular molecular pathways that lead to the progression of thyroid cancer. When these pathways are understood, specific drugs can be developed to block these changes. By comparing genomic differences between different thyroid cancers, our laboratory has identified genes that may play a role in determining their behavior. Furthermore, we have identified molecular factors that potentially promote thyroid cancer metastases. We are developing new strategies to target the genes associated with aggressive thyroid cancer behavior. By understanding the biology of individual tumors, we will be able to create personalized cancer treatment plans for our patients. I have joint appointments in Surgery and Biochemistry, and have been recruited to lead the endocrine surgery research program.

Publications

  • Poorly differentiated thyroid cancer

    Patel, Kepal N; Shaha, Ashok R 2014 Apr; 121-126, Current opinion in otolaryngology & head & neck surgery — id: 836212, year: 2014, page: 121, stat: Journal Article
  • Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer

    Dultz, Linda A; Dhar, Shumon; Ogilvie, Jennifer B; Heller, Keith S; Bar-Sagi, Dafna; Patel, Kepal N 2013 Dec; 1239-1245, Surgery — id: 629882, year: 2013, page: 1239, stat: Journal Article
  • Understanding barriers to care and knowledge of disease in hispanic patients with thyroid cancer: A focus group approach

    Leon, Guerrero A H; Bhatia, N D; Yu, J Z; Lim, I P; Patel, K N; Ogilvie, J B 2013 October; A63-A63, Thyroid — id: 628622, year: 2013, page: A63
Read All Publications (22)